カテゴリ： Inkwood Research, 世界, 医療/バイオ

眼科薬の世界市場2023年〜2032年

■ 英語タイトル：GLOBAL OPHTHALMIC DRUGS MARKET FORECAST 2023-2032

調査会社Inkwood Research社が発行したリサーチレポート（データ管理コード：INK24MAR001）■ 発行会社/調査会社：Inkwood Research
■ 商品コード：INK24MAR001
■ 発行日：2023年11月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：298
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール
■ 販売価格オプション（消費税別）
Single UserUSD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Enterprisewide PriceUSD4,500 ⇒換算￥684,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Inkwood Research社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[眼科薬の世界市場2023年〜2032年]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

主な調査結果世界の眼科薬市場は、2023～2032年の予測期間中にCAGR 6.09%を予測します。市場成長の背景には、加齢に伴う眼疾患に対する高齢化人口の脆弱性、薬物送達技術の進歩、眼疾患や障害の発生率の増加、医療制度が実施する積極的な償還政策などがあります。

市場動向
眼科薬は、緑内障、加齢黄斑変性症（AMD）、ドライアイ症候群、糖尿病性網膜症など、眼に関連する様々な疾患への対応において重要な役割を果たしています。眼科薬には、抗炎症薬、抗感染薬、抗緑内障薬など、さまざまな薬物クラスが含まれます。これらの薬剤は、炎症、感染症、眼圧上昇、網膜障害などの特定の疾患適応に対応するよう調整されています。

眼疾患や障害の世界的な有病率の増加は、人口統計学的要因、ライフスタイル要因、環境要因の組み合わせに起因しています。その一因として、スマートフォン、コンピューター、タブレットなどのデジタル機器の普及が挙げられ、これらの画面から発せられるブルーライトへの曝露が増加しています。このブルーライトに長時間さらされると、デジタル眼精疲労を引き起こし、ドライアイ、目の疲れ、不快感などの症状が現れます。それ自体は病気ではないが、デジタル眼精疲労は既存の目の状態を悪化させ、視覚的快適性に悪影響を及ぼす可能性があります。
しかし、特許の失効やジェネリック医薬品の参入が市場成長の課題となっています。新興国における未開発の可能性は、市場参入者に成長の道を提供します。

地域別動向
世界の眼科薬市場の成長評価には、北米、欧州、アジア太平洋地域、その他の地域の地理的分析が含まれます。アジア太平洋地域は世界市場で最も急成長している地域であり、眼疾患の有病率の増加、高齢化人口の増加、医薬品の研究開発の進歩などの様々な要因によって牽引されています。

競争に関する洞察
世界規模の眼科薬市場は、様々な製薬会社が市場シェアを争う激しい競争が特徴です。大手製薬企業は、新薬や新治療法の導入を目指した研究開発に多大な資源を投入し、継続的な技術革新のサイクルを促進しています。市場の大手企業には、AbbVie Inc、Genentech Inc、Bausch Health Companies Incなどがあります。

当レポートの内容は以下の通りです：
•　市場全体の主要な調査結果を探る
•　市場動向の戦略的内訳（促進要因、阻害要因、機会、課題）
•　全セグメント、サブセグメント、地域の3年間の過去データとともに、最低9年間の市場予測
•　市場セグメンテーション：主要セグメントの徹底的な評価と市場予測
•　地域別分析： 言及された地域と国レベルのセグメントを市場シェアとともに評価
•　主要分析： ポーターのファイブフォース分析、企業状況、オポチュニティマトリックス、主要購買基準など。
•　競争環境は、要因、市場シェアなどに基づく主要企業の理論的説明です。
•　企業情報： 詳細な会社概要、提供する製品・サービス、SCOT分析、最近の戦略的展開など

1. 調査範囲・調査方法
2. エグゼクティブサマリー
3. 市場動向
4. 主要分析
5. 世界の眼科薬市場規模：疾患別市場分析
6. 世界の眼科薬市場規模：種類別市場分析
7. 世界の眼科薬市場規模：剤形別市場分析
8. 世界の眼科薬市場規模：治療クラス別市場分析
9. 世界の眼科薬市場規模：流通チャネル別市場分析
10. 世界の眼科薬市場規模：地域別分析
11. 競争状況

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.4.1. IMPACT OF COVID-19 ON OPHTHALMIC DRUGS MARKET
2.5. MAJOR MARKET FINDINGS
2.5.1. EMERGING THERAPIES FOR DRY EYE SYNDROME
2.5.2. GROWING DEMAND FOR COMBINATION THERAPIES
2.5.3. INCREASING INVESTMENT IN RESEARCH & DEVELOPMENT
2.5.4. SHIFT TOWARD OVER-THE-COUNTER (OTC) PRODUCTS
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. AGING POPULATION’S SUSCEPTIBILITY TO AGE-RELATED EYE CONDITIONS
3.1.2. ADVANCEMENTS IN DRUG DELIVERY TECHNOLOGIES
3.1.3. RISING PREVALENCE OF EYE DISEASES AND DISORDERS
3.1.4. FAVORABLE REIMBURSEMENT POLICIES BY HEALTHCARE SYSTEMS
3.2. KEY RESTRAINTS
3.2.1. DELAY IN DRUG APPROVALS
3.2.2. SIDE EFFECTS RELATED TO OPHTHALMIC DRUGS
4. KEY ANALYTICS
4.1. KEY MARKET TRENDS
4.2. TECHNOLOGY SNAPSHOT
4.2.1. BIOLOGICS
4.2.2. CELL THERAPY
4.2.3. GENE THERAPY
4.2.4. DRUG DELIVERY
4.2.5. SMALL MOLECULE
4.2.6. OTHER TECHNOLOGIES
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. GROWTH PROSPECT MAPPING
4.4.1. GROWTH PROSPECT MAPPING FOR UNITED STATES
4.4.2. GROWTH PROSPECT MAPPING FOR ITALY
4.4.3. GROWTH PROSPECT MAPPING FOR INDIA
4.4.4. GROWTH PROSPECT MAPPING FOR THE MIDDLE EAST & AFRICA
4.5. MARKET MATURITY ANALYSIS
4.6. MARKET CONCENTRATION ANALYSIS
4.7. KEY BUYING CRITERIA
4.8. REGULATORY FRAMEWORK
5. MARKET BY INDICATION
5.1. DRY EYE
5.2. GLAUCOMA
5.3. INFECTION/INFLAMMATION/ALLERGIES
5.4. RETINAL DISORDER
5.4.1. WET AGE-RELATED MACULAR DEGENERATION
5.4.2. DRY AGE-RELATED MACULAR DEGENERATION
5.4.3. DIABETIC RETINOPATHY
5.4.4. OTHER RETINAL DISORDERS
5.5. OTHER INDICATIONS
6. MARKET BY TYPE
6.1. PRESCRIPTION DRUGS
6.2. OVER-THE-COUNTER DRUGS
7. MARKET BY DOSAGE FORM
7.1. GELS
7.2. EYE SOLUTIONS & SUSPENSIONS
7.3. CAPSULES & TABLETS
7.4. EYE DROPS
7.5. OINTMENTS
8. MARKET BY THERAPEUTIC CLASS
8.1. ANTI-GLAUCOMA
8.2. ANTI-INFECTION
8.3. ANTI-INFLAMMATORY
8.4. ANTI-ALLERGY
8.5. OTHER THERAPEUTIC CLASSES
9. MARKET BY DISTRIBUTION CHANNEL
9.1. HOSPITAL PHARMACIES
9.2. DRUG STORES
9.3. ONLINE PHARMACIES
9.4. OTHER DISTRIBUTION CHANNELS
10. GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1. MARKET SIZE & ESTIMATES
10.1.2. NORTH AMERICA OPHTHALMIC DRUGS MARKET DRIVERS
10.1.3. NORTH AMERICA OPHTHALMIC DRUGS MARKET CHALLENGES
10.1.4. KEY PLAYERS IN NORTH AMERICA OPHTHALMIC DRUGS MARKET
10.1.5. COUNTRY ANALYSIS
10.1.5.1. UNITED STATES
10.1.5.1.1. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.1.5.2. CANADA
10.1.5.2.1. CANADA OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.2. EUROPE
10.2.1. MARKET SIZE & ESTIMATES
10.2.2. EUROPE OPHTHALMIC DRUGS MARKET DRIVERS
10.2.3. EUROPE OPHTHALMIC DRUGS MARKET CHALLENGES
10.2.4. KEY PLAYERS IN EUROPE OPHTHALMIC DRUGS MARKET
10.2.5. COUNTRY ANALYSIS
10.2.5.1. UNITED KINGDOM
10.2.5.1.1. UNITED KINGDOM OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.2.5.2. GERMANY
10.2.5.2.1. GERMANY OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.2.5.3. FRANCE
10.2.5.3.1. FRANCE OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.2.5.4. ITALY
10.2.5.4.1. ITALY OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.2.5.5. SPAIN
10.2.5.5.1. SPAIN OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.2.5.6. BELGIUM
10.2.5.6.1. BELGIUM OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.2.5.7. POLAND
10.2.5.7.1. POLAND OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.2.5.8. REST OF EUROPE
10.2.5.8.1. REST OF EUROPE OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.3. ASIA-PACIFIC
10.3.1. MARKET SIZE & ESTIMATES
10.3.2. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET DRIVERS
10.3.3. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET CHALLENGES
10.3.4. KEY PLAYERS IN ASIA-PACIFIC OPHTHALMIC DRUGS MARKET
10.3.5. COUNTRY ANALYSIS
10.3.5.1. CHINA
10.3.5.1.1. CHINA OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.3.5.2. JAPAN
10.3.5.2.1. JAPAN OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.3.5.3. INDIA
10.3.5.3.1. INDIA OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.3.5.4. SOUTH KOREA
10.3.5.4.1. SOUTH KOREA OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.3.5.5. INDONESIA
10.3.5.5.1. INDONESIA OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.3.5.6. THAILAND
10.3.5.6.1. THAILAND OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.3.5.7. VIETNAM
10.3.5.7.1. VIETNAM OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.3.5.8. AUSTRALIA & NEW ZEALAND
10.3.5.8.1. AUSTRALIA & NEW ZEALAND OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.3.5.9. REST OF ASIA-PACIFIC
10.3.5.9.1. REST OF ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.4. REST OF WORLD
10.4.1. MARKET SIZE & ESTIMATES
10.4.2. REST OF WORLD OPHTHALMIC DRUGS MARKET DRIVERS
10.4.3. REST OF WORLD OPHTHALMIC DRUGS MARKET CHALLENGES
10.4.4. KEY PLAYERS IN REST OF WORLD OPHTHALMIC DRUGS MARKET
10.4.5. REGIONAL ANALYSIS
10.4.5.1. LATIN AMERICA
10.4.5.1.1. LATIN AMERICA OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.4.5.2. MIDDLE EAST & AFRICA
10.4.5.2.1. MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
11. COMPETITIVE LANDSCAPE
11.1. KEY STRATEGIC DEVELOPMENTS
11.1.1. MERGERS & ACQUISITIONS
11.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
11.1.3. PARTNERSHIPS & AGREEMENTS
11.2. COMPANY PROFILES
11.2.1. ABBVIE INC
11.2.1.1. COMPANY OVERVIEW
11.2.1.2. PRODUCTS & SERVICES
11.2.1.3. STRENGTHS & CHALLENGES
11.2.2. ACCUTOME INC
11.2.2.1. COMPANY OVERVIEW
11.2.2.2. PRODUCTS & SERVICES
11.2.2.3. STRENGTHS & CHALLENGES
11.2.3. BAUSCH HEALTH COMPANIES INC
11.2.3.1. COMPANY OVERVIEW
11.2.3.2. PRODUCTS & SERVICES
11.2.3.3. STRENGTHS & CHALLENGES
11.2.4. GENENTECH INC
11.2.4.1. COMPANY OVERVIEW
11.2.4.2. PRODUCTS & SERVICES
11.2.4.3. STRENGTHS & CHALLENGES
11.2.5. JOHNSON & JOHNSON
11.2.5.1. COMPANY OVERVIEW
11.2.5.2. PRODUCTS & SERVICES
11.2.5.3. STRENGTHS & CHALLENGES
11.2.6. THEA PHARMA INC
11.2.6.1. COMPANY OVERVIEW
11.2.6.2. PRODUCTS & SERVICES
11.2.6.3. STRENGTHS & CHALLENGES
11.2.7. NOVARTIS AG
11.2.7.1. COMPANY OVERVIEW
11.2.7.2. PRODUCTS & SERVICES
11.2.7.3. STRENGTHS & CHALLENGES
11.2.8. PFIZER INC
11.2.8.1. COMPANY OVERVIEW
11.2.8.2. PRODUCTS & SERVICES
11.2.8.3. STRENGTHS & CHALLENGES
11.2.9. REGENERON PHARMACEUTICALS INC
11.2.9.1. COMPANY OVERVIEW
11.2.9.2. PRODUCTS & SERVICES
11.2.9.3. STRENGTHS & CHALLENGES
11.2.10. SANTEN PHARMACEUTICAL CO LTD
11.2.10.1. COMPANY OVERVIEW
11.2.10.2. PRODUCTS & SERVICES
11.2.10.3. STRENGTHS & CHALLENGES
11.2.11. SUN PHARMACEUTICAL INDUSTRIES LTD
11.2.11.1. COMPANY OVERVIEW
11.2.11.2. PRODUCTS & SERVICES
11.2.11.3. STRENGTHS & CHALLENGES
11.2.12. TEVA PHARMACEUTICALS INDUSTRIES LTD
11.2.12.1. COMPANY OVERVIEW
11.2.12.2. PRODUCTS & SERVICES
11.2.12.3. STRENGTHS & CHALLENGES

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – OPHTHALMIC DRUGS
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: GLOBAL OPHTHALMIC DRUGS MARKET, BY INDICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 4: GLOBAL OPHTHALMIC DRUGS MARKET, BY INDICATION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 5: GLOBAL DRY EYE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 6: GLOBAL DRY EYE MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 7: GLOBAL GLAUCOMA MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 8: GLOBAL GLAUCOMA MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 9: GLOBAL INFECTION/INFLAMMATION/ALLERGIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 10: GLOBAL INFECTION/INFLAMMATION/ALLERGIES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 11: GLOBAL RETINAL DISORDER MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 12: GLOBAL RETINAL DISORDER MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 13: GLOBAL OPHTHALMIC DRUGS MARKET, BY RETINAL DISORDER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 14: GLOBAL OPHTHALMIC DRUGS MARKET, BY RETINAL DISORDER, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 15: GLOBAL WET AGE-RELATED MACULAR DEGENERATION MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 16: GLOBAL WET AGE-RELATED MACULAR DEGENERATION MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 17: GLOBAL DRY AGE-RELATED MACULAR DEGENERATION MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 18: GLOBAL DRY AGE-RELATED MACULAR DEGENERATION MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 19: GLOBAL DIABETIC RETINOPATHY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 20: GLOBAL DIABETIC RETINOPATHY MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 21: GLOBAL OTHER RETINAL DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 22: GLOBAL OTHER RETINAL DISORDERS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 23: GLOBAL OTHER INDICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 24: GLOBAL OTHER INDICATIONS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 25: GLOBAL OPHTHALMIC DRUGS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 26: GLOBAL OPHTHALMIC DRUGS MARKET, BY TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 27: GLOBAL PRESCRIPTION DRUGS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 28: GLOBAL PRESCRIPTION DRUGS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 29: GLOBAL OVER-THE-COUNTER DRUGS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 30: GLOBAL OVER-THE-COUNTER DRUGS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 31: GLOBAL OPHTHALMIC DRUGS MARKET, BY DOSAGE FORM, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 32: GLOBAL OPHTHALMIC DRUGS MARKET, BY DOSAGE FORM, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 33: GLOBAL GELS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 34: GLOBAL GELS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 35: GLOBAL EYE SOLUTIONS & SUSPENSIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 36: GLOBAL EYE SOLUTIONS & SUSPENSIONS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 37: GLOBAL CAPSULES & TABLETS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 38: GLOBAL CAPSULES & TABLETS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 39: GLOBAL EYE DROPS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 40: GLOBAL EYE DROPS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 41: GLOBAL OINTMENTS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 42: GLOBAL OINTMENTS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 43: GLOBAL OPHTHALMIC DRUGS MARKET, BY THERAPEUTIC CLASS, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 44: GLOBAL OPHTHALMIC DRUGS MARKET, BY THERAPEUTIC CLASS, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 45: GLOBAL ANTI-GLAUCOMA MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 46: GLOBAL ANTI-GLAUCOMA MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 47: GLOBAL ANTI-INFECTION MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 48: GLOBAL ANTI-INFECTION MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 49: GLOBAL ANTI-INFLAMMATORY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 50: GLOBAL ANTI-INFLAMMATORY MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 51: GLOBAL ANTI-ALLERGY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 52: GLOBAL ANTI-ALLERGY MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 53: GLOBAL OTHER THERAPEUTIC CLASSES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 54: GLOBAL OTHER THERAPEUTIC CLASSES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 55: GLOBAL OPHTHALMIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 56: GLOBAL OPHTHALMIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 57: GLOBAL HOSPITAL PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 58: GLOBAL HOSPITAL PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 59: GLOBAL DRUG STORES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 60: GLOBAL DRUG STORES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 61: GLOBAL ONLINE PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 62: GLOBAL ONLINE PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 63: GLOBAL OTHER DISTRIBUTION CHANNELS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 64: GLOBAL OTHER DISTRIBUTION CHANNELS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 65: GLOBAL OPHTHALMIC DRUGS MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 66: GLOBAL OPHTHALMIC DRUGS MARKET, BY GEOGRAPHY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 67: NORTH AMERICA OPHTHALMIC DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 68: NORTH AMERICA OPHTHALMIC DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 69: KEY PLAYERS OPERATING IN NORTH AMERICA OPHTHALMIC DRUGS MARKET
TABLE 70: EUROPE OPHTHALMIC DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 71: EUROPE OPHTHALMIC DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 72: KEY PLAYERS OPERATING IN EUROPE OPHTHALMIC DRUGS MARKET
TABLE 73: ASIA-PACIFIC OPHTHALMIC DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 74: ASIA-PACIFIC OPHTHALMIC DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 75: KEY PLAYERS OPERATING IN ASIA-PACIFIC OPHTHALMIC DRUGS MARKET
TABLE 76: REST OF WORLD OPHTHALMIC DRUGS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 77: REST OF WORLD OPHTHALMIC DRUGS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 78: KEY PLAYERS OPERATING IN REST OF WORLD OPHTHALMIC DRUGS MARKET
TABLE 79: LIST OF MERGERS & ACQUISITIONS
TABLE 80: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 81: LIST OF PARTNERSHIPS & AGREEMENTS

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 眼科薬のアジア太平洋市場2023年〜2032年
  • 男性不妊症の世界市場2023年〜2032年
  • 歯科用滅菌の世界市場2023年〜2032年
  • 煙感知器の世界市場2023年〜2032年
  • 眼瞼形成術の世界市場2024年〜2032年
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(INK24MAR001 )"眼科薬の世界市場2023年〜2032年" (英文：GLOBAL OPHTHALMIC DRUGS MARKET FORECAST 2023-2032)はInkwood Research社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。